SARS-CoV-2 Spike S1 Protein (RBD) (Biotin)

Catalog No. ABIN6953024

This Recombinant SARS-CoV-2 Spike S1 protein is produced in CHO Cells.

Quick Overview for SARS-CoV-2 Spike S1 Protein (RBD) (Biotin) (ABIN6953024)

Target: SARS-CoV-2 Spike S1

Protein Type: Recombinant

Origin: SARS Coronavirus-2 (SARS-CoV-2)

Source: CHO Cells

Purity: >95 % as determined by SDS-PAGE and HPLC

Product Details

Protein Characteristics: RBD

Purification tag / Conjugate: This SARS-CoV-2 Spike S1 protein is labelled with Biotin.

Characteristics: DNA sequence encoding the COVID-19 spike RBD protein domain [319-541] accession #6VSB_A including a C-terminal mouse IgG1 tag was expressed in CHO Cells.

Endotoxin Level: Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than 0.1 ng/μg(1EU/μg).

Application Details

Comment:

Recombinant 2019-nCoV RBD protein is a protein consisting of 460 amino acid residues ,due to glycosylation migrates as an approximately 52 kDa protein on SDS-PAGE.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: A quick spin of the vial followed by reconstitution in distilled water to a concentration not less than 0.1 mg/mL. This solution can then be diluted into other buffers

Buffer: Recombinant COVID-19 RBD (Receptor Binding Domain) protein was lyophilized from 0.2 μm filtered 20 mM Tris, 300 mM NaCl, 10 % glycerol, pH 8.0.

Storage: -20 °C

Storage Comment: The lyophilized protein is stable for at least 2 years from date of receipt at -20° C.

Target Details

Target: SARS-CoV-2 Spike S1

Target Type: Viral Protein

Gene ID: 43740568

UniProt: P0DTC2